What Analysts Are Saying About DermTech Stock
What Analysts Are Saying About DermTech Stock
分析师对DermTech股票的看法
DermTech (NASDAQ:DMTK) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
DermTech（纳斯达克股票代码：DMTK）在上个季度接受了4位分析师的分析，揭示了从看涨到看跌的一系列观点。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表简要概述了分析师最近的评级，提供了对过去30天情绪变化的见解，并与前几个月进行了比较以获得整体视角。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $1.41, a high estimate of $2.00, and a low estimate of $0.63. A 56.62% drop is evident in the current average compared to the previous average price target of $3.25.
分析师分析的12个月目标股价提供了见解，平均目标价为1.41美元，最高估计为2.00美元，低估值为0.63美元。与之前的平均目标股价3.25美元相比，当前的平均价格下降了56.62％。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析师评级：详细审查
The...
通...
登录免费看全文
登录/注册